ClarkP.A., “Placebo Surgery for Parkinson's Disease: Do the Benefits Outweigh the Risks?,”Journal of Law, Medicine & Ethics, 30, no. 1 (2002): 58–68.
2.
See BeecherH.K., “Surgery as Placebo,”JAMA, 176 (1961): 1102–07.
3.
EmanuelE.J.MillerF.G., “The Ethics of Placebo-Controlled Trials — A Middle Ground,”N. Engl. J. Med., 345 (2001): 915–19, at 917 (bullets added).
4.
FreedmanB.WeijerC.GlassK.C., “Placebo Orthodoxy in Clinical Research I: Empirical and Methodological Myths,”Journal of Law, Medicine & Ethics, 24 (1996): 243–51.
5.
See id.
6.
WeijerC., “The Ethical Analysis of Risk,”Journal of Law, Medicine & Ethics, 28, no. 4 (2000): 344–61.
7.
U.S. National Bioethics Advisory Commission, “Report and Recommendations of the National Advisory Bioethics Commission,”Ethical and Policy Issues in Research Involving Human Participants, vol. 1 (Bethesda: NBAC, 2001).
8.
See Weijer, supra note 6.
9.
See id.
10.
See id.
11.
See Clark, supra note 1.
12.
WeijerC., “Research Involving the Vulnerable Sick,”Accountability in Research, 7 (1999): 21–36.
13.
See LevineR.J., Ethics and Regulation of Clinical Research, 2d ed. (New Haven: Yale University Press, 1988): at 73.